Haleon Shares Fall as H1 Revenue Misses, Growth Lags Target

Haleon plc (HLN) shares fell on Tuesday after the consumer healthcare company reported first-half 2026 results that missed revenue estimates and showed organic growth trailing its own medium-term targets. The disappointing top-line performance overshadowed the company's decision to reaffirm its full-year guidance and declare an interim dividend.

Growth Concerns Weigh on Stock

Haleon reported first-half revenue of approximately £5.55 billion, falling short of analyst consensus estimates of around £5.62 billion. Organic revenue grew by 2.6% during the period, a figure composed of 2.1% from price increases and 0.5% from volume and mix.

This growth rate remains significantly below the company’s stated medium-term annual target range of 4–6%, a key point of concern for investors. Despite the miss, Haleon maintained its full-year 2026 outlook and announced an interim dividend of 2.4 pence per share.

A Mixed Quarterly Picture

While the half-year figures disappointed, the results showed a sequential acceleration in the second quarter. Q2 organic sales growth reached 3.1%, up from 2.2% in Q1, though this still narrowly missed the 3.2% consensus forecast.

Ad

A closer look at the quarterly performance reveals a mixed picture:

• Pricing: Grew 1.7%, below the 1.9% analysts had expected.
• Volume & Mix: Increased by 1.4%, beating forecasts.
• North America: Like-for-like sales expanded 3.1%, also ahead of expectations.

Analyst Caution and Sector Headwinds

The market's negative reaction reflects a "sell-the-news" sentiment, which was amplified by recent analyst caution. In the weeks preceding the report, Deutsche Bank had issued a Sell rating and JPMorgan had cut its price target, both flagging execution risk.

The results land amid broader scrutiny of the consumer healthcare sector, where peers like Kenvue and Procter & Gamble also face pressure to shift from a price-led growth model to one driven by a sustained recovery in sales volumes. Following the report, Haleon shares traded down 2.2% to 371.5 pence.